ONTOLOGY REPORT - ANNOTATIONS
| Term: | N-ethyl-N-nitrosourea |
|
| Accession: | CHEBI:23995
|
browse the term
|
| Definition: | A urea compound having ethyl and nitroso substituents in the 1-position. |
| Synonyms: | related_synonym: | 1-(Aminocarbonyl)-1-ethyl-2-oxohydrazine; 1-Ethyl-1-nitrosourea; Aethylnitroso-harnstoff; C3H7N3O2; CCN(N=O)C(N)=O; ENU; Ethyl nitrosourea; InChI=1S/C3H7N3O2/c1-2-6(5-8)3(4)7/h2H2,1H3,(H2,4,7); InChIKey=FUSGACRLAFQQRL-UHFFFAOYSA-N; N-Ethyl-N-nitroso carbamide; N-Ethyl-N-nitroso-urea; N-Ethylnitrosourea; NEU |
| | xref_casrn: | 759-73-9 |
| | xref: | Beilstein:1761174 "Beilstein Registry Number"; ChEMBL:377890 "ChEMBL COMPOUND"; ChemIDplus:759-73-9 "CAS Registry Number" |
| | xref_mesh: | MESH:D005038 |
| | xref: | NIST Chemistry WebBook:759-73-9 "CAS Registry Number" |
|
|
N-ethyl-N-nitrosourea
|
| G |
Abcg5 |
ATP-binding cassette, subfamily G (WHITE), member 5 |
|
increases mutagenesis |
EXP |
6 |
8,027,647 |
8,064,425 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
increases expression |
EXP |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Actn4 |
actinin alpha 4 |
|
increases expression |
EXP |
1 |
84,000,723 |
84,073,767 |
RGD:6480464 |
CTD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
increases mutagenesis |
EXP |
3 |
114,867,357 |
114,869,680 |
RGD:6480464 |
CTD |
| G |
Aen |
apoptosis enhancing nuclease |
|
increases expression |
ISO |
1 |
134,615,998 |
134,625,367 |
RGD:6480464 |
CTD |
| G |
Aff1 |
AF4/FMR2 family, member 1 |
|
increases mutagenesis |
ISO |
14 |
7,015,191 |
7,114,671 |
RGD:6480464 |
CTD |
| G |
Alg5 |
ALG5, dolichyl-phosphate beta-glucosyltransferase |
|
increases mutagenesis |
ISO |
2 |
143,962,038 |
143,975,765 |
RGD:6480464 |
CTD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
increases mutagenesis |
ISO |
6 |
23,009,061 |
23,730,939 |
RGD:6480464 |
CTD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
multiple interactions |
ISO |
6 |
23,009,061 |
23,730,939 |
RGD:6480464 |
CTD |
| G |
Ankrd11 |
ankyrin repeat domain 11 |
|
increases mutagenesis |
ISO |
19 |
53,208,631 |
53,242,478 |
RGD:6480464 |
CTD |
| G |
Antxr1 |
anthrax toxin receptor 1 |
|
increases mutagenesis |
ISO |
4 |
121,297,955 |
121,483,876 |
RGD:6480464 |
CTD |
| G |
Ap2a1 |
adaptor-related protein complex 2, alpha 1 subunit |
|
increases mutagenesis |
ISO |
1 |
95,373,135 |
95,403,376 |
RGD:6480464 |
CTD |
| G |
Apc |
adenomatous polyposis coli |
|
increases mutagenesis |
ISO |
18 |
26,732,147 |
26,790,383 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
increases mutagenesis |
ISO |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Arcn1 |
archain 1 |
|
increases mutagenesis |
ISO |
8 |
47,699,348 |
47,725,337 |
RGD:6480464 |
CTD |
| G |
Arl13b |
ADP-ribosylation factor-like 13B |
|
increases mutagenesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Asip |
agouti signaling protein |
|
increases mutagenesis |
ISO |
3 |
145,445,175 |
145,536,831 |
RGD:6480464 |
CTD |
| G |
Asip |
agouti signaling protein |
|
increases mutagenesis |
ISO |
3 |
145,445,175 |
145,536,831 |
RGD:6480464 |
CTD |
| G |
Atrx |
alpha thalassemia/mental retardation syndrome X-linked |
|
increases mutagenesis |
EXP |
X |
93,903,794 |
94,051,337 |
RGD:6480464 |
CTD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
increases mutagenesis |
EXP |
7 |
62,225,537 |
62,229,461 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcat2 |
branched chain amino acid transaminase 2, mitochondrial |
|
increases mutagenesis |
ISO |
1 |
96,038,287 |
96,055,622 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases mutagenesis |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
increases mutagenesis |
ISO |
8 |
80,593,053 |
80,717,015 |
RGD:6480464 |
CTD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
increases mutagenesis |
ISO |
8 |
80,593,053 |
80,717,015 |
RGD:6480464 |
CTD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
increases mutagenesis |
ISO |
8 |
80,593,053 |
80,717,015 |
RGD:6480464 |
CTD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
increases mutagenesis |
ISO |
8 |
80,593,053 |
80,717,015 |
RGD:6480464 |
CTD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
increases mutagenesis |
ISO |
8 |
80,593,053 |
80,717,015 |
RGD:6480464 |
CTD |
| G |
Brwd1 |
bromodomain and WD repeat domain containing 1 |
|
increases mutagenesis |
ISO |
11 |
36,303,503 |
36,385,878 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
increases mutagenesis |
ISO |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
increases mutagenesis |
ISO |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
|
increases mutagenesis |
ISO |
8 |
112,643,409 |
112,775,460 |
RGD:6480464 |
CTD |
| G |
Capsl |
calcyphosine-like |
|
increases mutagenesis |
ISO |
2 |
59,043,383 |
59,066,371 |
RGD:6480464 |
CTD |
| G |
Card11 |
caspase recruitment domain family, member 11 |
|
increases mutagenesis |
ISO |
12 |
14,165,040 |
14,229,267 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
increases mutagenesis |
EXP |
1 |
163,156,914 |
163,166,969 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases mutagenesis |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases mutagenesis |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
increases mutagenesis |
ISO |
3 |
89,243,600 |
89,245,129 |
RGD:6480464 |
CTD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
multiple interactions |
EXP |
3 |
89,243,600 |
89,245,129 |
RGD:6480464 |
CTD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
multiple interactions |
EXP |
3 |
89,243,600 |
89,245,129 |
RGD:6480464 |
CTD |
| G |
Cd83 |
CD83 molecule |
|
increases mutagenesis |
ISO |
17 |
26,705,646 |
26,725,470 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases response to substance |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
|
increases mutagenesis |
ISO |
7 |
123,900,366 |
124,036,122 |
RGD:6480464 |
CTD |
| G |
Chgb |
chromogranin B (secretogranin 1) |
|
increases expression |
EXP |
3 |
120,571,736 |
120,584,874 |
RGD:6480464 |
CTD |
| G |
Chrm5 |
cholinergic receptor, muscarinic 5 |
|
increases mutagenesis |
EXP |
3 |
98,326,809 |
98,378,531 |
RGD:6480464 |
CTD |
| G |
Chrna6 |
cholinergic receptor, nicotinic, alpha 6 (neuronal) |
|
increases mutagenesis |
EXP |
16 |
69,012,201 |
69,018,901 |
RGD:6480464 |
CTD |
| G |
Chrnd |
cholinergic receptor, nicotinic, delta (muscle) |
|
increases mutagenesis |
EXP |
9 |
85,996,421 |
86,004,839 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
increases mutagenesis |
ISO |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Cryaa |
crystallin, alpha A |
|
increases mutagenesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Crygb |
crystallin, gamma B |
|
increases mutagenesis |
ISO |
9 |
63,730,906 |
63,732,966 |
RGD:6480464 |
CTD |
| G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
20 |
4,125,357 |
4,128,518 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
increases mutagenesis |
EXP |
15 |
53,647,500 |
53,648,429 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
increases mutagenesis |
EXP |
3 |
6,052,706 |
6,069,826 |
RGD:6480464 |
CTD |
| G |
Dcbld2 |
discoidin, CUB and LCCL domain containing 2 |
|
increases mutagenesis |
EXP |
11 |
42,941,795 |
42,980,245 |
RGD:6480464 |
CTD |
| G |
Dfnb59 |
deafness, autosomal recessive 59 |
|
increases mutagenesis |
ISO |
3 |
59,348,728 |
59,356,706 |
RGD:6480464 |
CTD |
| G |
Disp1 |
dispatched homolog 1 (Drosophila) |
|
increases mutagenesis |
ISO |
13 |
99,095,659 |
99,242,282 |
RGD:6480464 |
CTD |
| G |
Disp1 |
dispatched homolog 1 (Drosophila) |
|
increases mutagenesis |
ISO |
13 |
99,095,659 |
99,242,282 |
RGD:6480464 |
CTD |
| G |
Dmd |
dystrophin |
|
increases mutagenesis |
ISO |
X |
71,501,362 |
71,671,414 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
increases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
increases mutagenesis |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Dst |
dystonin |
|
increases mutagenesis |
ISO |
9 |
32,757,554 |
33,051,275 |
RGD:6480464 |
CTD |
| G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
|
increases mutagenesis |
ISO |
6 |
135,318,083 |
135,391,459 |
RGD:6480464 |
CTD |
| G |
Dync2h1 |
dynein cytoplasmic 2 heavy chain 1 |
|
increases mutagenesis |
ISO |
8 |
3,826,843 |
4,072,644 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
increases mutagenesis |
ISO |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases mutagenesis |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases mutagenesis |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases mutagenesis |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases mutagenesis |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Emx2 |
empty spiracles homeobox 2 |
|
increases mutagenesis |
ISO |
1 |
266,004,257 |
266,011,265 |
RGD:6480464 |
CTD |
| G |
Enam |
enamelin |
|
increases mutagenesis |
ISO |
14 |
21,137,021 |
21,162,644 |
RGD:6480464 |
CTD |
| G |
Enam |
enamelin |
|
increases mutagenesis |
ISO |
14 |
21,137,021 |
21,162,644 |
RGD:6480464 |
CTD |
| G |
Enam |
enamelin |
|
increases mutagenesis |
ISO |
14 |
21,137,021 |
21,162,644 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
increases mutagenesis |
EXP |
10 |
87,219,157 |
87,242,919 |
RGD:6480464 |
CTD |
| G |
Fah |
fumarylacetoacetate hydrolase |
|
increases mutagenesis |
ISO |
1 |
140,851,975 |
140,876,187 |
RGD:6480464 |
CTD |
| G |
Fah |
fumarylacetoacetate hydrolase |
|
increases mutagenesis |
ISO |
1 |
140,851,975 |
140,876,187 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
decreases expression |
EXP |
15 |
42,425,336 |
42,453,390 |
RGD:6480464 |
CTD |
| G |
Fech |
ferrochelatase |
|
increases mutagenesis |
ISO |
18 |
60,675,217 |
60,708,418 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxn1 |
forkhead box N1 |
|
increases mutagenesis |
ISO |
10 |
64,243,323 |
64,256,847 |
RGD:6480464 |
CTD |
| G |
Frem1 |
Fras1 related extracellular matrix 1 |
|
increases mutagenesis |
ISO |
5 |
101,773,603 |
101,891,178 |
RGD:6480464 |
CTD |
| G |
Fshr |
follicle stimulating hormone receptor |
|
increases mutagenesis |
EXP |
6 |
12,925,894 |
13,161,215 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
increases expression |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
increases mutagenesis |
ISO |
X |
26,564,259 |
26,572,081 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
multiple interactions |
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
increases activity |
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
increases mutagenesis |
ISO |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
increases mutagenesis |
ISO |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
increases mutagenesis |
ISO |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
increases mutagenesis |
ISO |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
increases mutagenesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases mutagenesis |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases mutagenesis |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases mutagenesis |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
multiple interactions |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gjb2 |
gap junction protein, beta 2 |
|
increases mutagenesis |
ISO |
15 |
36,153,526 |
36,159,490 |
RGD:6480464 |
CTD |
| G |
Gli3 |
GLI family zinc finger 3 |
|
increases mutagenesis |
ISO |
17 |
57,594,102 |
57,867,710 |
RGD:6480464 |
CTD |
| G |
Glra1 |
glycine receptor, alpha 1 |
|
increases mutagenesis |
ISO |
10 |
40,922,867 |
41,021,767 |
RGD:6480464 |
CTD |
| G |
Gna11 |
guanine nucleotide binding protein, alpha 11 |
|
increases mutagenesis |
ISO |
7 |
9,636,748 |
9,662,492 |
RGD:6480464 |
CTD |
| G |
Gnaq |
guanine nucleotide binding protein (G protein), q polypeptide |
|
increases mutagenesis |
ISO |
1 |
219,520,998 |
219,764,401 |
RGD:6480464 |
CTD |
| G |
Gnas |
GNAS complex locus |
|
increases mutagenesis |
ISO |
3 |
165,213,399 |
165,214,551 |
RGD:6480464 |
CTD |
| G |
Gnrhr |
gonadotropin releasing hormone receptor |
|
increases mutagenesis |
ISO |
14 |
23,625,135 |
23,656,583 |
RGD:6480464 |
CTD |
| G |
Gpr115 |
G protein-coupled receptor 115 |
|
increases mutagenesis |
EXP |
9 |
14,006,763 |
14,122,217 |
RGD:6480464 |
CTD |
| G |
Gpr33 |
G protein-coupled receptor 33 |
|
increases mutagenesis |
ISO |
6 |
72,176,407 |
72,177,412 |
RGD:6480464 |
CTD |
| G |
Gpr98 |
G protein-coupled receptor 98 |
|
increases mutagenesis |
ISO |
2 |
8,851,539 |
8,915,885 |
RGD:6480464 |
CTD |
| G |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
|
increases mutagenesis |
ISO |
4 |
92,642,427 |
94,054,757 |
RGD:6480464 |
CTD |
| G |
Grik1 |
glutamate receptor, ionotropic, kainate 1 |
|
increases mutagenesis |
EXP |
11 |
27,703,874 |
28,106,450 |
RGD:6480464 |
CTD |
| G |
Grm6 |
glutamate receptor, metabotropic 6 |
|
increases mutagenesis |
ISO |
10 |
36,421,806 |
36,436,909 |
RGD:6480464 |
CTD |
| G |
Grm8 |
glutamate receptor, metabotropic 8 |
|
increases mutagenesis |
EXP |
4 |
53,976,781 |
54,902,331 |
RGD:6480464 |
CTD |
| G |
Grpr |
gastrin releasing peptide receptor |
|
increases mutagenesis |
EXP |
X |
51,743,248 |
51,783,255 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects response to substance |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Hadhb |
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
|
increases mutagenesis |
ISO |
6 |
26,139,397 |
26,173,428 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
increases expression |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hectd1 |
HECT domain containing E3 ubiquitin protein ligase 1 |
|
increases mutagenesis |
ISO |
6 |
71,842,842 |
71,930,042 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
decreases expression |
EXP |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hoxd12 |
homeo box D12 |
|
increases mutagenesis |
ISO |
3 |
57,290,344 |
57,291,465 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
increases mutagenesis |
EXP |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hr |
hair growth associated |
|
increases mutagenesis |
ISO |
15 |
50,957,053 |
50,972,842 |
RGD:6480464 |
CTD |
| G |
Hr |
hair growth associated |
|
increases mutagenesis |
ISO |
15 |
50,957,053 |
50,972,842 |
RGD:6480464 |
CTD |
| G |
Hr |
hair growth associated |
|
increases mutagenesis |
ISO |
15 |
50,957,053 |
50,972,842 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
increases response to substance |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
increases mutagenesis |
EXP |
9 |
11,033,496 |
11,038,868 |
RGD:6480464 |
CTD |
| G |
Htt |
huntingtin |
|
increases mutagenesis |
EXP |
14 |
81,490,322 |
81,636,856 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
EXP |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
increases expression |
EXP |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Ift172 |
intraflagellar transport 172 homolog (Chlamydomonas) |
|
increases mutagenesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ift88 |
intraflagellar transport 88 homolog (Chlamydomonas) |
|
increases mutagenesis |
ISO |
15 |
36,468,007 |
36,560,959 |
RGD:6480464 |
CTD |
| G |
Ift88 |
intraflagellar transport 88 homolog (Chlamydomonas) |
|
increases mutagenesis |
ISO |
15 |
36,468,007 |
36,560,959 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
increases mutagenesis |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igj |
immunoglobulin joining chain |
|
increases mutagenesis |
ISO |
14 |
21,109,762 |
21,126,014 |
RGD:6480464 |
CTD |
| G |
Ikzf1 |
IKAROS family zinc finger 1 |
|
increases mutagenesis |
ISO |
14 |
92,560,200 |
92,657,336 |
RGD:6480464 |
CTD |
| G |
Il7 |
interleukin 7 |
|
increases mutagenesis |
ISO |
2 |
96,356,083 |
96,399,796 |
RGD:6480464 |
CTD |
| G |
Il7 |
interleukin 7 |
|
increases mutagenesis |
ISO |
2 |
96,356,083 |
96,399,796 |
RGD:6480464 |
CTD |
| G |
Ina |
internexin neuronal intermediate filament protein, alpha |
|
increases expression |
EXP |
1 |
252,328,186 |
252,340,997 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
increases mutagenesis |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
decreases expression |
EXP |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
increases mutagenesis |
ISO |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Itpkb |
inositol-trisphosphate 3-kinase B |
|
increases mutagenesis |
ISO |
13 |
96,044,260 |
96,138,456 |
RGD:6480464 |
CTD |
| G |
Jag1 |
jagged 1 |
|
increases mutagenesis |
ISO |
3 |
125,181,063 |
125,216,481 |
RGD:6480464 |
CTD |
| G |
Jak3 |
Janus kinase 3 |
|
increases mutagenesis |
ISO |
16 |
18,878,139 |
18,889,441 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kcne1 |
potassium voltage-gated channel, Isk-related family, member 1 |
|
increases mutagenesis |
ISO |
11 |
32,344,529 |
32,355,189 |
RGD:6480464 |
CTD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
increases mutagenesis |
ISO |
1 |
96,614,960 |
96,617,993 |
RGD:6480464 |
CTD |
| G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
increases mutagenesis |
ISO |
4 |
180,144,084 |
180,149,935 |
RGD:6480464 |
CTD |
| G |
Kcnq1 |
potassium voltage-gated channel, KQT-like subfamily, member 1 |
|
increases mutagenesis |
ISO |
1 |
203,383,401 |
203,803,687 |
RGD:6480464 |
CTD |
| G |
Kcnq2 |
potassium voltage-gated channel, KQT-like subfamily, member 2 |
|
increases mutagenesis |
ISO |
3 |
170,227,938 |
170,282,887 |
RGD:6480464 |
CTD |
| G |
Kif3a |
kinesin family member 3a |
|
increases mutagenesis |
ISO |
10 |
39,029,351 |
39,062,570 |
RGD:6480464 |
CTD |
| G |
Kif3a |
kinesin family member 3a |
|
increases mutagenesis |
ISO |
10 |
39,029,351 |
39,062,570 |
RGD:6480464 |
CTD |
| G |
Kiss1r |
KISS1 receptor |
|
increases mutagenesis |
EXP |
7 |
11,297,840 |
11,301,187 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
increases mutagenesis |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
increases mutagenesis |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
increases mutagenesis |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
l7Rn6 |
lethal, Chr 7, Rinchik 6 |
|
increases mutagenesis |
ISO |
1 |
146,522,014 |
146,545,388 |
RGD:6480464 |
CTD |
| G |
Lama2 |
laminin, alpha 2 |
|
increases mutagenesis |
ISO |
1 |
18,203,466 |
18,885,462 |
RGD:6480464 |
CTD |
| G |
Large |
like-glycosyltransferase |
|
increases mutagenesis |
EXP |
19 |
12,043,818 |
12,497,663 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
increases mutagenesis |
ISO |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
increases mutagenesis |
ISO |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
increases mutagenesis |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
increases mutagenesis |
EXP |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Lhx2 |
LIM homeobox 2 |
|
decreases expression |
EXP |
3 |
18,129,455 |
18,147,357 |
RGD:6480464 |
CTD |
| G |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
|
increases mutagenesis |
ISO |
1 |
206,102,750 |
206,206,350 |
RGD:6480464 |
CTD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
increases mutagenesis |
ISO |
20 |
3,657,842 |
3,659,848 |
RGD:6480464 |
CTD |
| G |
Lum |
lumican |
|
increases expression |
EXP |
7 |
35,083,480 |
35,090,284 |
RGD:6480464 |
CTD |
| G |
Lxn |
latexin |
|
increases expression |
EXP |
2 |
157,310,036 |
157,315,905 |
RGD:6480464 |
CTD |
| G |
Mapk6 |
mitogen-activated protein kinase 6 |
|
increases expression |
EXP |
8 |
80,212,726 |
80,236,362 |
RGD:6480464 |
CTD |
| G |
Mbd1 |
methyl-CpG binding domain protein 1 |
|
increases expression |
ISO |
18 |
71,068,257 |
71,082,734 |
RGD:6480464 |
CTD |
| G |
Mbd1 |
methyl-CpG binding domain protein 1 |
|
increases expression |
ISO |
18 |
71,068,257 |
71,082,734 |
RGD:6480464 |
CTD |
| G |
Mc3r |
melanocortin 3 receptor |
|
increases mutagenesis |
ISO |
3 |
163,158,776 |
163,159,873 |
RGD:6480464 |
CTD |
| G |
Mc4r |
melanocortin 4 receptor |
|
increases mutagenesis |
ISO |
18 |
63,390,922 |
63,392,809 |
RGD:6480464 |
CTD |
| G |
Mc4r |
melanocortin 4 receptor |
|
increases mutagenesis |
ISO |
18 |
63,390,922 |
63,392,809 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mecp2 |
methyl CpG binding protein 2 |
|
increases expression |
ISO |
X |
159,980,599 |
160,035,260 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
increases expression |
EXP |
6 |
91,137,262 |
91,139,751 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
EXP |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases alkylation |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
EXP |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
increases expression |
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
multiple interactions |
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
increases mutagenesis |
EXP |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
increases mutagenesis |
EXP |
6 |
11,525,292 |
11,542,592 |
RGD:6480464 |
CTD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
increases mutagenesis |
EXP |
6 |
11,525,292 |
11,542,592 |
RGD:6480464 |
CTD |
| G |
Mt-nd1 |
mitochondrially encoded NADH dehydrogenase 1 |
|
decreases expression |
ISO |
MT |
2,740 |
3,694 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
increases mutagenesis |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
increases mutagenesis |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
increases mutagenesis |
ISO |
8 |
124,299,729 |
124,303,798 |
RGD:6480464 |
CTD |
| G |
Myo5a |
myosin VA |
|
increases mutagenesis |
ISO |
8 |
79,909,224 |
80,027,290 |
RGD:6480464 |
CTD |
| G |
Myo5a |
myosin VA |
|
increases mutagenesis |
ISO |
8 |
79,909,224 |
80,027,290 |
RGD:6480464 |
CTD |
| G |
Myo5a |
myosin VA |
|
increases mutagenesis |
ISO |
8 |
79,909,224 |
80,027,290 |
RGD:6480464 |
CTD |
| G |
Myo5a |
myosin VA |
|
increases mutagenesis |
ISO |
8 |
79,909,224 |
80,027,290 |
RGD:6480464 |
CTD |
| G |
Myo6 |
myosin VI |
|
increases mutagenesis |
ISO |
8 |
85,203,987 |
85,368,026 |
RGD:6480464 |
CTD |
| G |
Myo7a |
myosin VIIA |
|
increases mutagenesis |
EXP |
1 |
155,292,620 |
155,362,698 |
RGD:6480464 |
CTD |
| G |
Myoc |
myocilin, trabecular meshwork inducible glucocorticoid response |
|
increases mutagenesis |
EXP |
13 |
78,303,830 |
78,314,228 |
RGD:6480464 |
CTD |
| G |
Ncaph2 |
non-SMC condensin II complex, subunit H2 |
|
increases mutagenesis |
ISO |
7 |
127,650,768 |
127,666,461 |
RGD:6480464 |
CTD |
| G |
Nckap1 |
NCK-associated protein 1 |
|
increases mutagenesis |
ISO |
3 |
63,191,700 |
63,274,021 |
RGD:6480464 |
CTD |
| G |
Net1 |
neuroepithelial cell transforming 1 |
|
increases expression |
ISO |
17 |
77,533,225 |
77,543,337 |
RGD:6480464 |
CTD |
| G |
Nfix |
nuclear factor I/X (CCAAT-binding transcription factor) |
|
decreases expression |
EXP |
19 |
25,018,352 |
25,111,367 |
RGD:6480464 |
CTD |
| G |
Nfya |
nuclear transcription factor-Y alpha |
|
multiple interactions |
ISO |
9 |
7,970,040 |
7,994,375 |
RGD:6480464 |
CTD |
| G |
Nfya |
nuclear transcription factor-Y alpha |
|
increases activity |
ISO |
9 |
7,970,040 |
7,994,375 |
RGD:6480464 |
CTD |
| G |
Nlgn3 |
neuroligin 3 |
|
increases mutagenesis |
EXP |
X |
89,376,193 |
89,398,665 |
RGD:6480464 |
CTD |
| G |
Nmur2 |
neuromedin U receptor 2 |
|
increases mutagenesis |
EXP |
10 |
41,471,179 |
41,485,043 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases mutagenesis |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Npr3 |
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
|
increases mutagenesis |
ISO |
2 |
61,278,264 |
61,341,460 |
RGD:6480464 |
CTD |
| G |
Npy2r |
neuropeptide Y receptor Y2 |
|
increases mutagenesis |
EXP |
2 |
150,554,962 |
150,556,108 |
RGD:6480464 |
CTD |
| G |
Npy4r |
neuropeptide Y receptor Y4 |
|
increases mutagenesis |
EXP |
16 |
9,787,170 |
9,788,426 |
RGD:6480464 |
CTD |
| G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
increases mutagenesis |
EXP |
5 |
151,524,685 |
151,528,000 |
RGD:6480464 |
CTD |
| G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
increases mutagenesis |
EXP |
10 |
87,541,246 |
87,548,186 |
RGD:6480464 |
CTD |
| G |
Nsun7 |
NOP2/Sun domain family, member 7 |
|
increases mutagenesis |
ISO |
14 |
44,556,251 |
44,582,930 |
RGD:6480464 |
CTD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
increases mutagenesis |
EXP |
17 |
11,494,463 |
11,811,654 |
RGD:6480464 |
CTD |
| G |
Nts |
neurotensin |
|
increases mutagenesis |
EXP |
7 |
40,474,654 |
40,484,058 |
RGD:6480464 |
CTD |
| G |
Nup133 |
nucleoporin 133 |
|
increases mutagenesis |
ISO |
19 |
54,089,391 |
54,139,882 |
RGD:6480464 |
CTD |
| G |
Oprl1 |
opiate receptor-like 1 |
|
increases mutagenesis |
EXP |
3 |
170,869,862 |
170,873,417 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
increases mutagenesis |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Otof |
otoferlin |
|
increases mutagenesis |
ISO |
6 |
25,912,607 |
26,008,137 |
RGD:6480464 |
CTD |
| G |
Otof |
otoferlin |
|
increases mutagenesis |
ISO |
6 |
25,912,607 |
26,008,137 |
RGD:6480464 |
CTD |
| G |
Otop1 |
otopetrin 1 |
|
increases mutagenesis |
ISO |
14 |
77,784,515 |
77,811,966 |
RGD:6480464 |
CTD |
| G |
Pak4 |
p21 protein (Cdc42/Rac)-activated kinase 4 |
|
increases mutagenesis |
ISO |
1 |
83,670,786 |
83,710,070 |
RGD:6480464 |
CTD |
| G |
Pax3 |
paired box 3 |
|
increases mutagenesis |
ISO |
9 |
77,477,813 |
77,576,632 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
increases mutagenesis |
ISO |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
increases mutagenesis |
ISO |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcsk5 |
proprotein convertase subtilisin/kexin type 5 |
|
increases mutagenesis |
ISO |
1 |
220,961,912 |
221,405,907 |
RGD:6480464 |
CTD |
| G |
Pde6b |
phosphodiesterase 6B, cGMP-specific, rod, beta |
|
increases mutagenesis |
ISO |
14 |
1,871,037 |
1,914,170 |
RGD:6480464 |
CTD |
| G |
Pdp1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
|
increases expression |
EXP |
5 |
26,234,414 |
26,240,301 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
multiple interactions |
EXP |
X |
50,797,413 |
50,812,217 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
increases mutagenesis |
EXP |
X |
50,797,413 |
50,812,217 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
multiple interactions |
EXP |
X |
50,797,413 |
50,812,217 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
increases mutagenesis |
EXP |
X |
50,797,413 |
50,812,217 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
increases mutagenesis |
EXP |
X |
50,797,413 |
50,812,217 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
increases mutagenesis |
EXP |
X |
50,797,413 |
50,812,217 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
increases mutagenesis |
EXP |
X |
50,797,413 |
50,812,217 |
RGD:6480464 |
CTD |
| G |
Pink1 |
PTEN induced putative kinase 1 |
|
increases mutagenesis |
EXP |
5 |
157,091,181 |
157,103,293 |
RGD:6480464 |
CTD |
| G |
Pkd1 |
polycystic kidney disease 1 homolog (human) |
|
increases mutagenesis |
ISO |
10 |
13,801,445 |
13,848,212 |
RGD:6480464 |
CTD |
| G |
Plaa |
phospholipase A2, activating protein |
|
increases expression |
EXP |
5 |
114,869,341 |
114,899,356 |
RGD:6480464 |
CTD |
| G |
Plcg2 |
phospholipase C, gamma 2 |
|
increases mutagenesis |
ISO |
19 |
47,875,572 |
47,947,573 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
increases expression |
ISO |
2 |
41,800,745 |
41,806,503 |
RGD:6480464 |
CTD |
| G |
Pmch |
pro-melanin-concentrating hormone |
|
increases mutagenesis |
EXP |
7 |
24,778,133 |
24,779,449 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
increases mutagenesis |
ISO |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Polq |
polymerase (DNA directed), theta |
|
increases mutagenesis |
ISO |
11 |
65,474,661 |
65,577,382 |
RGD:6480464 |
CTD |
| G |
Pomt1 |
protein-O-mannosyltransferase 1 |
|
increases mutagenesis |
EXP |
3 |
11,348,786 |
11,366,633 |
RGD:6480464 |
CTD |
| G |
Ppia |
peptidylprolyl isomerase A (cyclophilin A) |
|
increases expression |
EXP |
14 |
87,165,998 |
87,169,995 |
RGD:6480464 |
CTD |
| G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
|
increases expression |
ISO |
1 |
240,991,884 |
240,996,887 |
RGD:6480464 |
CTD |
| G |
Prkar2b |
protein kinase, cAMP dependent regulatory, type II beta |
|
increases expression |
EXP |
6 |
50,234,979 |
50,325,298 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases mutagenesis |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases mutagenesis |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
increases mutagenesis |
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
decreases expression |
EXP |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Qk |
quaking |
|
increases mutagenesis |
ISO |
1 |
44,922,562 |
45,025,572 |
RGD:6480464 |
CTD |
| G |
Rab14 |
RAB14, member RAS oncogene family |
|
decreases expression |
EXP |
3 |
14,245,693 |
14,255,984 |
RGD:6480464 |
CTD |
| G |
Rab23 |
RAB23, member RAS oncogene family |
|
increases mutagenesis |
ISO |
9 |
32,465,752 |
32,486,615 |
RGD:6480464 |
CTD |
| G |
Rab3a |
RAB3A, member RAS oncogene family |
|
increases mutagenesis |
ISO |
16 |
19,189,765 |
19,193,874 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases expression |
EXP |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rcan1 |
regulator of calcineurin 1 |
|
increases expression |
ISO |
11 |
32,386,576 |
32,408,850 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
increases mutagenesis |
EXP |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
increases mutagenesis |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rho |
rhodopsin |
|
increases mutagenesis |
ISO |
4 |
152,057,788 |
152,062,950 |
RGD:6480464 |
CTD |
| G |
Rpl27a |
ribosomal protein L27a |
|
increases mutagenesis |
ISO |
1 |
167,115,389 |
167,118,407 |
RGD:6480464 |
CTD |
| G |
Rprd1a |
regulation of nuclear pre-mRNA domain containing 1A |
|
increases mutagenesis |
EXP |
18 |
16,283,291 |
16,328,357 |
RGD:6480464 |
CTD |
| G |
Rrm2b |
ribonucleotide reductase M2 B (TP53 inducible) |
|
increases expression |
ISO |
7 |
73,432,161 |
73,459,541 |
RGD:6480464 |
CTD |
| G |
Rs1 |
retinoschisin 1 |
|
increases mutagenesis |
ISO |
X |
55,242,654 |
55,266,251 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
decreases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scn8a |
sodium channel, voltage gated, type VIII, alpha subunit |
|
increases mutagenesis |
ISO |
7 |
139,686,180 |
139,794,282 |
RGD:6480464 |
CTD |
| G |
Scn8a |
sodium channel, voltage gated, type VIII, alpha subunit |
|
increases mutagenesis |
ISO |
7 |
139,686,180 |
139,794,282 |
RGD:6480464 |
CTD |
| G |
Scnm1 |
sodium channel modifier 1 |
|
increases mutagenesis |
ISO |
2 |
190,035,097 |
190,039,027 |
RGD:6480464 |
CTD |
| G |
Sema3c |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
|
increases mutagenesis |
ISO |
4 |
13,739,659 |
13,914,636 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
increases expression |
EXP |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Shh |
sonic hedgehog |
|
increases mutagenesis |
ISO |
4 |
2,200,504 |
2,209,657 |
RGD:6480464 |
CTD |
| G |
Sim1 |
single-minded homolog 1 (Drosophila) |
|
increases mutagenesis |
ISO |
20 |
54,908,178 |
54,988,099 |
RGD:6480464 |
CTD |
| G |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
|
increases mutagenesis |
ISO |
10 |
91,454,824 |
91,471,072 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases mutagenesis |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
increases mutagenesis |
EXP |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
increases mutagenesis |
EXP |
X |
159,570,789 |
159,580,093 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
increases mutagenesis |
ISO |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Smad4 |
SMAD family member 4 |
|
increases mutagenesis |
ISO |
18 |
70,432,705 |
70,461,541 |
RGD:6480464 |
CTD |
| G |
Smo |
smoothened, frizzled family receptor |
|
increases mutagenesis |
ISO |
4 |
56,623,494 |
56,645,571 |
RGD:6480464 |
CTD |
| G |
Smo |
smoothened, frizzled family receptor |
|
increases mutagenesis |
ISO |
4 |
56,623,494 |
56,645,571 |
RGD:6480464 |
CTD |
| G |
Snn |
stannin |
|
increases expression |
EXP |
10 |
4,486,038 |
4,494,711 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
increases expression |
EXP |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
increases mutagenesis |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
increases mutagenesis |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stx2 |
syntaxin 2 |
|
increases mutagenesis |
ISO |
12 |
28,751,591 |
28,773,351 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
increases mutagenesis |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Tbx6 |
T-box 6 |
|
increases mutagenesis |
ISO |
1 |
185,957,068 |
185,960,977 |
RGD:6480464 |
CTD |
| G |
Tbx6 |
T-box 6 |
|
increases mutagenesis |
ISO |
1 |
185,957,068 |
185,960,977 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases mutagenesis |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tlr9 |
toll-like receptor 9 |
|
increases mutagenesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases mutagenesis |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases mutagenesis |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases mutagenesis |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases mutagenesis |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases mutagenesis |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Ttc21b |
tetratricopeptide repeat domain 21B |
|
increases mutagenesis |
ISO |
3 |
48,147,053 |
48,222,257 |
RGD:6480464 |
CTD |
| G |
Tubb4b |
tubulin, beta 4B class IVb |
|
increases expression |
ISO |
3 |
3,387,050 |
3,389,500 |
RGD:6480464 |
CTD |
| G |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
|
increases mutagenesis |
ISO |
6 |
52,605,869 |
52,607,863 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
increases mutagenesis |
ISO |
1 |
143,641,257 |
143,746,315 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
increases mutagenesis |
ISO |
1 |
143,641,257 |
143,746,315 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
increases mutagenesis |
ISO |
1 |
143,641,257 |
143,746,315 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
increases mutagenesis |
ISO |
1 |
143,641,257 |
143,746,315 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
increases mutagenesis |
ISO |
1 |
143,641,257 |
143,746,315 |
RGD:6480464 |
CTD |
| G |
Tyrp1 |
tyrosinase-related protein 1 |
|
increases mutagenesis |
ISO |
5 |
99,518,306 |
99,537,289 |
RGD:6480464 |
CTD |
| G |
Tyrp1 |
tyrosinase-related protein 1 |
|
increases mutagenesis |
ISO |
5 |
99,518,306 |
99,537,289 |
RGD:6480464 |
CTD |
| G |
Tyrp1 |
tyrosinase-related protein 1 |
|
increases mutagenesis |
ISO |
5 |
99,518,306 |
99,537,289 |
RGD:6480464 |
CTD |
| G |
Tyrp1 |
tyrosinase-related protein 1 |
|
increases mutagenesis |
ISO |
5 |
99,518,306 |
99,537,289 |
RGD:6480464 |
CTD |
| G |
Tyrp1 |
tyrosinase-related protein 1 |
|
increases mutagenesis |
ISO |
5 |
99,518,306 |
99,537,289 |
RGD:6480464 |
CTD |
| G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
increases expression |
EXP |
5 |
77,263,334 |
77,295,794 |
RGD:6480464 |
CTD |
| G |
Ugdh |
UDP-glucose 6-dehydrogenase |
|
increases mutagenesis |
ISO |
14 |
45,542,781 |
45,570,961 |
RGD:6480464 |
CTD |
| G |
Usp29 |
ubiquitin specific peptidase 29 |
|
increases mutagenesis |
ISO |
1 |
65,272,956 |
65,326,368 |
RGD:6480464 |
CTD |
| G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
decreases expression |
ISO |
1 |
79,834,167 |
79,860,300 |
RGD:6480464 |
CTD |
| G |
Xrcc3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
affects response to substance |
ISO |
6 |
136,594,276 |
136,602,069 |
RGD:6480464 |
CTD |
| G |
Zap70 |
zeta-chain (TCR) associated protein kinase 70 |
|
increases mutagenesis |
ISO |
9 |
35,693,089 |
35,715,071 |
RGD:6480464 |
CTD |
| G |
Zfp111 |
zinc finger protein 111 |
|
increases mutagenesis |
ISO |
1 |
79,416,956 |
79,428,180 |
RGD:6480464 |
CTD |
| G |
Zfp568 |
zinc finger protein 568 |
|
increases mutagenesis |
ISO |
1 |
85,017,615 |
85,048,658 |
RGD:6480464 |
CTD |
| G |
Zfpm2 |
zinc finger protein, multitype 2 |
|
increases mutagenesis |
ISO |
7 |
76,210,472 |
76,654,443 |
RGD:6480464 |
CTD |
| G |
Zic2 |
Zic family member 2 |
|
increases mutagenesis |
ISO |
15 |
107,609,060 |
107,613,169 |
RGD:6480464 |
CTD |
| G |
Zim1 |
zinc finger, imprinted 1 |
|
increases mutagenesis |
ISO |
1 |
65,535,900 |
65,557,221 |
RGD:6480464 |
CTD |
Term paths to the root
|